IP Verse

Grnenthal patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Grnenthal opposed by its competitors

Explore Grnenthal's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 28, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3995135
Jul 13, 2022Prolonged Release Dosage Form Of Tapentadol L-(+)- Tartaric Acid Salt2
EP3210965
Nov 17, 2021Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol3
EP3656765
Apr 14, 2021Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol6
EP3241550
Jul 22, 2020(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful Inflammations4
EP3287123
Apr 22, 2020Aqueous Pharmaceutical Formulation Of Tapentadol For Oral Administration1
EP2694050
Oct 2, 2019Tapentadol For Treating Pain Associated With Trigeminal Neuralgia1
EP2694049
Oct 31, 2018Tapentadol For Preventing Chronification Of Pain3
EP1845956
Mar 22, 2017Break-Resistant Delayed-Release Forms Of Administration1